[The antipsychotic action of neuroleptics and basal ganglia function].
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001479:Basal Ganglia / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced; D002421:Caudate Nucleus / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism; D005116:Extrapyramidal Tracts; D006651:Histocytochemistry; D006801:Humans; D009044:Motor Cortex / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced; D009433:Neural Inhibition; D009434:Neural Pathways / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines; D051381:Rats; D012012:Red Nucleus / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology*
D014150:Antipsychotic Agents; D002090:Butyrophenones; D018377:Neurotransmitter Agents; D010640:Phenothiazines; D014149:Tranquilizing Agents; D012110:Reserpine; D000661:Amphetamine; D004298:Dopamine
Antipsikhoticheskoe deĭstvie neĭroleptikov i funktsiia bazal'nykh gangliev.